{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:49:25Z","timestamp":1761569365070,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.clgc.2022.08.007","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T13:01:12Z","timestamp":1661778072000},"page":"e70-e77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bladder tumor Resection Weight as a Prognostic Factor for Recurrence and Progression in Patients With High-Risk Non-Muscle Invasive Bladder Treated With BCG"],"prefix":"10.1016","volume":"21","author":[{"given":"Oliver C.","family":"Hald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih Chyn","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles J.M.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2022.08.007_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2022.08.007_bib0002","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: an update","volume":"38","author":"Richters","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.28397","article-title":"Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006","volume":"120","author":"Nielsen","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2022.08.007_bib0004","unstructured":"Comp\u00e9rat E, Gontero P, Liedberg F, et\u00a0al. EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) 2021."},{"key":"10.1016\/j.clgc.2022.08.007_bib0005","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.eururo.2020.04.066","volume":"78","author":"Grimm","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumor progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0007","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s10147-020-01654-5","article-title":"A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables","volume":"25","author":"Miyake","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0008","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0009","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4111\/kju.2012.53.7.457","article-title":"Multivariate analysis of the prognostic significance of resection weight after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer","volume":"53","author":"Kwon","year":"2012","journal-title":"Korean J Urol"},{"issue":"4 Pt B","key":"10.1016\/j.clgc.2022.08.007_bib0011","first-page":"E196","article-title":"Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumor","volume":"111","author":"De La Pe\u00f1a","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2022.08.007_bib0012","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/21681805.2019.1708968","article-title":"The value of tumor weight as a predictive factor for recurrence and progression in non-muscle invasive bladder cancer","volume":"54","author":"Fern\u00e1ndez-Conejo","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0013","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.2015.64.4070","article-title":"Definitions, end points, and clinical trial designs for non-muscle-invasive bladder cancer: recommendations from the international bladder cancer group","volume":"34","author":"Kamat","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eururo.2012.08.064","article-title":"Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer","volume":"63","author":"Thomas","year":"2013","journal-title":"European Urology"},{"key":"10.1016\/j.clgc.2022.08.007_bib0015","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1827.2009.02477.x","article-title":"Non-invasive papillary urothelial neoplasms: the 2004 WHO\/ISUP classification system","volume":"60","author":"Miyamoto","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.clgc.2022.08.007_bib0017","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/BLC-179020","article-title":"Letter to the Editor: Bacillus Calmette-Guerin (BCG) treatment failures with non-muscle invasive bladder cancer: a data-driven definition for BCG unresponsive disease","volume":"3","author":"Li","year":"2017","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.clgc.2022.08.007_bib0018","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.juro.2013.07.102","article-title":"Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition","volume":"191","author":"Lamm","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2022.08.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/745742","article-title":"smoothHR: an R package for pointwise nonparametric estimation of hazard ratio curves of continuous predictors","volume":"2013","author":"Meira-Machado","year":"2013","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.clgc.2022.08.007_bib0020","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000343666","article-title":"Size of bladder cancers: correlation among different types of measurement","volume":"90","author":"Racioppi","year":"2013","journal-title":"Urol Int"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322001768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767322001768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:37:17Z","timestamp":1761565037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767322001768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1558767322001768"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2022.08.007","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bladder tumor Resection Weight as a Prognostic Factor for Recurrence and Progression in Patients With High-Risk Non-Muscle Invasive Bladder Treated With BCG","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2022.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}